Related Experiment Video
Updated: Jul 14, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
The silent regulators: non-coding RNAs and Epstein-Barr virus at the crossroads of lupus pathogenesis
Andrea Picchianti-Diamanti1, Alessandra Rai1, Stella Mrmić1
1Department of Clinical and Molecular Medicine, Sapienza University of Rome, S. Andrea University Hospital, Rome, Italy.
None:
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease driven by immune dysregulation, chronic inflammation, and loss of immune tolerance. Increasing evidence suggests that non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs, and circular RNAs, are involved in the fine regulation of immune responses, epigenetic changes, and cytokine signaling in SLE. Their altered expression has been associated with disease activity, specific clinical phenotypes, and treatment response, supporting their potential as biomarkers. Epstein-Barr virus (EBV), a long-suspected contributor to SLE, may further shape disease through persistent immune activation, molecular mimicry, and modulation of host ncRNA pathways. In this review, we examine how EBV and ncRNA dysregulation may converge in autoreactive B cells and other immune compartments to promote the loss of tolerance and the development of clinically distinct forms of SLE. We also discuss the implications of this axis for biomarker development and emerging therapeutic strategies, including personalized immune-targeted approaches.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Inhibitors of Viral Protein Synthesis
Leaky Scanning
